Latest News in Pharma industry6 hours agoLomecel-B Receives FDA Designation for Alzheimer's Treatment6 hours agoFDA Committee Recommends Splitting NSCLC Trials11 hours agoCalliditas Therapeutics Makes Breakthrough in Treating Liver Condition11 hours agoMedidata's Game-Changing Clinical Data Studio1 day agoDeepc Raises Additional $13M in Series A Funding1 day agoTRiCares Receives $50M Funding for Topaz Heart Valve System1 day agoAutobahn Therapeutics Raises $100M for Innovative Treatments1 day agoAbbVie Inc. Reports Strong Q2 Earnings2 days agoTop AstraZeneca China Executives Arrested in Massive CTLA4 Drug Smuggling Bust2 days agoPfizer's Breakthrough Gene Therapy for Hemophilia A2 days agoParatek Pharmaceuticals Reports Positive Results for Nuzyra Antibiotic2 days agoAI-Powered Dental Diagnostics: Pearl Secures $58 Million in Series B Funding2 days agoNeuspera Medical Completes Successful Trial for Implantable SNM System2 days agoBoston Scientific Reports Strong Q2 Results2 days agoLummus Technology and Element Six Join Forces to Tackle PFAS Destruction3 days agoWegovy: U.K. Approval for Preventing Heart Problems3 days agoIonis Pharmaceuticals Reports Positive Results for ION582 in Angelman Syndrome Study4 days agoRevolutionary Nanoparticle Technology to Treat Abdominal Aortic Aneurysm4 days agoCEPI Expands Vaccine Partnership for Chikungunya Outbreak4 days agoSergey Brin's Catalyst4 Invests $15M in Psychedelic Biotech Soneira5 days agoShiba Inu Team's Warning: Beware of Scammers and Bounce Back After WazirX Hack6 days agoEmbecta's Potential Sale Amid Market Challenges7 days agoMicrobot's Liberty System Hits Milestone in Surgical Robotics7 days agoHow Trumps Win or Lose will Affect Health-Care Stocks7 days agoBayer Expanding Nubeqa Label for Prostate Cancer7 days agoSeraph 100 Technology Shows 94% CTC Reduction in Pancreatic Cancer Patients9 days agoIntegra Therapeutics Receives €10.5M Funding from EU's EIC Accelerator9 days agoSpinal Muscular Atrophy Market Set to Grow9 days agoAzafaros Reports Promising Trial Results for Nizubaglustat in Treating Rare Neurological Disorders9 days agoRite Aid: Massive Data Breach Exposes 2.2 Million Customers10 days agoHims & Hers (HIMS) Stock Soars with New Weight Loss Drug10 days agoRevolution Medicine Readies Phase III Trial for RMC-623610 days agoRise Therapeutics Initiates Phase Ib Trial for R-5280 Oral Immunotherapy10 days agoCamurus Reports Positive Results for Acromegaly Treatment10 days agoCF Industries and POET Join Forces for Low-Carbon Ammonia Program11 days agoBiopharma Sector Struggles with Resilience Amid Pandemic Pressures, Survey Reveals Persistent Supply Chain and Talent Woes11 days agoSpur Therapeutics Advances Gene Therapy for Gaucher Disease to Phase III11 days agoFluGen's M2SR and Sanofi's Fluzone HD Combo Enhances Flu Protection14 days agoUniQure's AMT-130 Gene Therapy Shows Promising Results14 days agoVivani Medical Set to Launch Clinical Trial for Innovative Obesity Implant15 days agoKazia Therapeutics' Paxalisib Shows Promising Results in Glioblastoma Treatment15 days agoBiopharma Industry Struggles Amid Pandemic Fallout16 days agoAmylyx Pharmaceuticals Acquires Avexitide for Phase III Trial16 days agoBreakthrough Gene Therapy for Hemophilia B Showcases Transformative Impact in France16 days agoJaguar Gene Therapy Receives FDA Clearance for Phase I Clinical Trial16 days agoFTC Investigates PBMs' Impact on Drug Costs17 days agoiTeos Secures $35M Funding for Phase III Trial with GSK17 days agoStudy Shows GLP-1 Drugs Linked to Lower Cancer Risks17 days agoIdeaya Biosciences Unveils Promising Cancer Treatment Results17 days agoNew Amsterdam Pharma Completes Phase III Trial for Combination TherapyLoad More
